DXCM (DexCom) Other Current Liabilities: $33 Mil (As of Mar. 2026)


DXCM DexCom Inc DXCM
90 GF Score
Price $68.86
GF Value $103.77
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is DexCom Other Current Liabilities?

DexCom DXCM +2.24% 90 Other Current Liabilities is $33 Mil as of Mar. 2026. GuruFocus rates DXCM with a GF Score™ of 90/100 and a GF Value™ of $103.77 (Significantly Undervalued). The stock has 3 warning signs investors should review.

DexCom's other current liabilities for the quarter that ended in Mar. 2026 was $33 Mil.

DexCom's quarterly other current liabilities increased from Sep. 2025 ($28 Mil) to Dec. 2025 ($35 Mil) but then declined from Dec. 2025 ($35 Mil) to Mar. 2026 ($33 Mil).

DexCom's annual other current liabilities increased from Dec. 2023 ($31 Mil) to Dec. 2024 ($38 Mil) but then declined from Dec. 2024 ($38 Mil) to Dec. 2025 ($35 Mil).

DexCom Other Current Liabilities Related Terms

DexCom Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for DexCom's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DexCom Other Current Liabilities Chart

DexCom Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.40 37.50 31.20 37.50 34.60

DexCom Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.30 36.20 28.30 34.60 32.90
DXCM
90GF Score
DexCom Inc DXCM
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DexCom Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $33 Mil mean?
DexCom (DXCM) has a Other Current Liabilities of $33 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on DexCom.
Is DexCom's Other Current Liabilities too high?
DexCom's current Other Current Liabilities is $33 Mil. Overall, DexCom has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DexCom's Other Current Liabilities compare to GEHC and STE?
DexCom's Other Current Liabilities of $33 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on DexCom. DexCom's current Other Current Liabilities is $33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DexCom stock overvalued right now?
Based on GuruFocus' analysis, DexCom (DXCM) is currently considered Significantly Undervalued. The stock's GF Value™ is $103.77, compared to a current price of $68.86 — trading 33.6% below its estimated fair value. The current Other Current Liabilities is $33 Mil. DexCom's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For DexCom (DXCM), the current Other Current Liabilities is $33 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DexCom (DXCM) Overvalued in 2026?

Based on GuruFocus' analysis, DexCom stock appears to be undervalued. The current stock price of $68.86 is trading 33.6% below its estimated GF Value™ of $103.77. GuruFocus considers DexCom to be Significantly Undervalued.

Key valuation signals for DXCM:

  • Other Current Liabilities: $33 Mil
  • GF Value™: $103.77 vs. price of $68.86 (33.6% below fair value)
  • GF Score™: 90/100 with 3 warning signs

No single metric tells the full story. See the DXCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DexCom Business Description

Address 6340 Sequence Drive, San Diego, CA, USA, 92121
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
90GF Score

Get the complete analysis for DXCM

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$68.86
Price
$103.77
GF Value